Krystal Biotech
(NASDAQ) KRYS
Krystal Biotech Financials at a Glance
Market Cap
$8.02B
Revenue (TTM)
$389.13M
Net Income (TTM)
$204.83M
EPS (TTM)
$6.84
P/E Ratio
40.06
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$274.18
Volume
327,189.579
Open
$268.88
Price
$274.18
Volume
327,189.579
Open
$268.88
Previous Close
$274.21
Daily Range
$267.31 - $276.24
52-Week Range
$122.80 - $298.30
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$274.18
Volume
327,189.579
Open
$268.88
Previous Close
$274.21
Daily Range
$267.31 - $276.24
52-Week Range
$122.80 - $298.30
KRYS News
KRYS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Krystal Biotech
Industry
Biotechnology
Sector
Health CareEmployees
295
CEO
Krish S. Krishnan, MBA
Website
www.krystalbio.comHeadquarters
Pittsburgh, PA 15203, US
KRYS Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
41%
Net Income Margin
53%
Return on Equity
19%
Return on Capital
13%
Return on Assets
15%
Earnings Yield
2.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.02B
Shares Outstanding
29.23M
Volume
327.19K
Short Interest
0.00%
Avg. Volume
287.31K
Financials (TTM)
Gross Profit
$360.36M
Operating Income
$161.29M
EBITDA
$167.85M
Operating Cash Flow
$200.87M
Capital Expenditure
$11.95M
Free Cash Flow
$188.91M
Cash & ST Invst.
$827.79M
Total Debt
$9.34M
Krystal Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$107.11M
+17.5%
Gross Profit
$96.19M
+11.6%
Gross Margin
89.81%
N/A
Market Cap
$8.02B
N/A
Market Cap/Employee
$29.15M
N/A
Employees
275
N/A
Net Income
$51.40M
+13.0%
EBITDA
$39.61M
-7.7%
Quarterly Fundamentals
Net Cash
$818.45M
+38.7%
Accounts Receivable
$127.42M
+21.7%
Inventory
$40.48M
+52.7%
Long Term Debt
$7.57M
+25.2%
Short Term Debt
$1.77M
+45.5%
Return on Assets
15.36%
N/A
Return on Invested Capital
13.10%
N/A
Free Cash Flow
$75.37M
+44.8%
Operating Cash Flow
$77.51M
+46.7%